Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...
Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...
Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...
A stage 4 prostate cancer survivor shares his story of positivity and gratitude. After doing some yard landscaping, I began to have some rather severe back pain and muscle spasms. My first thought was ...
With the amazing advances in medicine in the last one hundred years, we are living longer and generally enjoying a higher quality of life as we age. Hip and knee replacements allow us to carry on with ...
I’m proud to say I’ve got one testicle, because I beat cancer and I’ve got the rest of my life to look forward to.” The ...
Free prostate cancer screening for men 40+ on Sat., March 21, 10 a.m.–2 p.m. at Pike County Health Department in Troy; no ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
News-Medical.Net on MSN
Low baseline testosterone predicts aggressive prostate cancer progression risk
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...
Medlife Crisis on MSN
Does prostate cancer screening actually save lives? New study explains
A new long-term study published in the New England Journal of Medicine followed 160,000 men for over two decades to examine ...
Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...
News-Medical.Net on MSN
FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results